• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1125325-23
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Stroke/CVA (1770); Nausea (1970); Neurological Deficit/Dysfunction (1982); Dizziness (2194)
Event Date 12/18/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Relevant tests/laboratory data, including dates: on (b)(6) 2015: ecg=no myocardial infarction; on (b)(6) 2015 (08:29): ck=44 u/l, normal upper limit 192; on (b)(6) 2015 (08:29): ck-mb=1.4 ng/ml, normal upper limit 2.9; on (b)(6) 2015 (08:29): troponin i=0.03 ng/ml, upper reference limit 0.03; on (b)(6) 2015: ecg=no new myocardial infarction; on (b)(6) 2015 (16:25): ck-mb=1.0 ng/ml, normal upper limit 4.9; on (b)(6) 2015 (16:25): troponin i=0.03 ng/ml, upper reference limit 0.03.(b)(4).It is indicated that the device is not returning for evaluation; therefore, a failure analysis of the complaint device could not be completed.The investigation was unable to determine a definitive cause for the patient effect.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of angina and nausea, as listed in the xience alpine everolimus eluting coronary stent system electronic instructions for use are known patient effects that may be associated with use of a coronary stent in native coronary arteries.Although a conclusive cause for the reported patient effects and the relationship to the product, if any, cannot be determined, there is no indication of a product quality issue with respect to manufacturing, design or labeling.
 
Event Description
It was reported that on (b)(6) 2015, the patient underwent a coronary procedure with implantation of a 3.25 x 23 mm xience alpine stent in the mid left anterior descending artery.Post procedure, the patient experienced altered mental status, evidenced by dizziness, difficulty speaking and nausea.Computed tomography (ct) scan and magnetic resonance imaging (mri) were ordered.Mri showed a tiny acute left cerebellar infarction.No intervention or treatment was performed.The patient underwent physical therapy, speech therapy and occupational therapy evaluation.The patient had full neurological recovery on (b)(6) 2015.On (b)(6) 2015, the patient experienced a non-serious episode of angina, with shortness of breath and jaw pain.Medication (nitrates) was administered and the angina resolved the day of onset.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key5365299
MDR Text Key35918570
Report Number2024168-2016-00232
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 01/13/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/13/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/14/2018
Device Catalogue Number1125325-23
Device Lot Number5090841
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/23/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability;
Patient Age70 YR
Patient Weight81
-
-